quality assessment

质量评价
  • 文章类型: Journal Article
    远程测序赋予了对其他遗传信息的深入了解,除了可以通过短读和现代长读技术访问的遗传信息之外。一些新的测序技术可用于远程数据集,如“Hi-C”和“关联读取”,具有高通量和高分辨率的基因组分析,并迅速推进基因组组装领域,基因组支架,和更全面的变体识别。在这篇文章中,我们专注于五种主要的远程测序技术:高通量染色体构象捕获(Hi-C),10x基因组学关联阅读,单列标签,转座酶酶连接长读测序(TELL-seq),和单管长片段读数(stLFR)。我们详细介绍了五大平台的机制和数据产品,介绍了几个最重要的应用,评估了来自不同平台的测序数据的质量,并讨论了目前可用的生物信息学工具。我们希望这项工作将有助于为特定的生物学研究选择合适的远程技术。
    Long-range sequencing grants insight into additional genetic information beyond that which can be accessed by both short reads and modern long-read technology. Several new sequencing technologies are available for long-range datasets such as \"Hi-C\" and \"Linked Reads\" with high-throughput and high-resolution genome analysis, and are rapidly advancing the field of genome assembly, genome scaffolding, and more comprehensive variant identification. In this article, we focused on five major long-range sequencing technologies: high-throughput chromosome conformation capture (Hi-C), 10x Genomics Linked Reads, haplotagging, transposase enzyme linked long-read sequencing (TELL-seq), and single tube long fragment read (stLFR). We detailed the mechanisms and data products of the five platforms, introduced several of the most important applications, evaluated the quality of sequencing data from different platforms, and discussed the currently available bioinformatics tools. We hope this work will benefit the selection of appropriate long-range technology for specific biological studies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    益生菌行业的快速扩张需要快速,敏感,全面,和低成本的质量评估策略。这里,我们引入了无文化,单细胞分辨率,表型-基因组组合策略称为单细胞鉴定,活力和活力测试,和来源追踪(SCIVVS)。对于直接从产品中提取的每个细胞,D2O探测的单细胞拉曼光谱(SCRS)的指纹区域能够以93%的准确率进行物种级识别,基于来自21种法定益生菌物种的参考SCRS数据库,而C-D波段准确地量化了生存能力,代谢活力加上它们的细胞间异质性。对于源跟踪,单细胞拉曼激活的细胞分选和测序可以进行,生产索引,精确的基于单细胞的基因组组装,可以达到~99.40%的全基因组覆盖率。最后,wevalidedanintegratedSCIVVSworkflowwithautomaticallySCRSacquisitionwherethewholeprocessexceptsequencingtakesjust5h.Asitis>20-foldhigher,>10倍便宜,活力-揭示,异质性解决,易于自动化,SCIVVS是一种用于活细胞产品质量评估的新技术和数据框架。
    Rapid expansion of the probiotics industry demands fast, sensitive, comprehensive, and low-cost strategies for quality assessment. Here, we introduce a culture-free, one-cell-resolution, phenome-genome-combined strategy called Single-Cell Identification, Viability and Vitality tests, and Source-tracking (SCIVVS). For each cell directly extracted from the product, the fingerprint region of D2O-probed single-cell Raman spectrum (SCRS) enables species-level identification with 93% accuracy, based on a reference SCRS database from 21 statutory probiotic species, whereas the C-D band accurately quantifies viability, metabolic vitality plus their intercellular heterogeneity. For source-tracking, single-cell Raman-activated Cell Sorting and Sequencing can proceed, producing indexed, precisely one-cell-based genome assemblies that can reach ~99.40% genome-wide coverage. Finally, we validated an integrated SCIVVS workflow with automated SCRS acquisition where the whole process except sequencing takes just 5 h. As it is >20-fold faster, >10-time cheaper, vitality-revealing, heterogeneity-resolving, and automation-prone, SCIVVS is a new technological and data framework for quality assessment of live-cell products.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这项研究的目的是评估临床实践指南(CPGs)和儿科牛乳蛋白过敏(CMPA)专家共识中建议的质量和一致性,为将来修订和增强临床指南和共识文件奠定基础。我们在几个数据库中进行了全面的文献检索,包括中国生物医学文献数据库(CBM),PubMed,Embase,WebofScience,UpToDate,ClinicalKey,DynaMedPlus和BMJ最佳实践。我们跨越了从每个数据库开始到2023年10月1日的搜索期。我们将主题词(MeSH/Emtree)和关键词整合到搜索策略中,使用现有文献的搜索方法,并与图书馆员合作开发。两名训练有素的研究人员独立进行了文献筛选和数据提取。我们通过使用研究与评估指南II(AGREEII)和AGREE-卓越推荐(AGREE-REX)工具评估了方法学质量和建议。此外,我们比较并总结了高质量CPG的关键建议。我们的研究包括27个CPG和关于CMPA的专家共识文件。只有四个CPG(14.8%)获得了高质量的AGREEII评级。四个高质量的CPG始终为CMPA提供建议。AGREEII的得分最高的领域是“范围和目的”(77±12%)和“呈现清晰度”(75±22%)。得分最低的领域是“利益相关者参与”(49±21%),“发展的严谨性”(34±20%)和“适用性”(12±20%)。使用AGREE-REX进行的评估通常显示其领域得分较低。结论:儿科CMPA的高质量CPG中的建议显示出基本的一致性。然而,CPG的方法和推荐内容以及专家共识表现出低质量,因此表明有很大的增强空间。指南开发人员应严格遵循AGREEII和AGREE-REX标准,以创建CPG或专家共识,以确保其在管理儿科CMPA中的临床疗效。已知内容:•关于儿科牛乳蛋白过敏(CMPA)的临床实践指南和专家共识的质量仍然不确定。•CMPA管理的关键建议的一致性缺乏明确性。提高指南的方法学质量和CMPA共识需要更加重视利益相关者的参与,严格的开发过程,和实际适用性。•四项高质量准则的建议保持一致。然而,解决临床适用性,整合价值观和偏好,确保可操作的实施对于提高所有准则的质量至关重要。
    The objective of this study was to assess the quality and consistency of recommendations in clinical practice guidelines (CPGs) and expert consensus on paediatric cow\'s milk protein allergy (CMPA) to serve as a foundation for future revisions and enhancements of clinical guidelines and consensus documents. We conducted a comprehensive literature search across several databases, including the Chinese Biomedical Literature Database (CBM), PubMed, Embase, Web of Science, UpToDate, ClinicalKey, DynaMed Plus and BMJ Best Practice. We spanned the search period from the inception of each database through October 1, 2023. We integrated subject headings (MeSH/Emtree) and keywords into the search strategy, used the search methodologies of existing literature and developed it in collaboration with a librarian. Two trained researchers independently conducted the literature screening and data extraction. We evaluated methodological quality and recommendations by using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) and AGREE-Recommendations for Excellence (AGREE-REX) tools. Moreover, we compared and summarized key recommendations from high-quality CPGs. Our study included 27 CPGs and expert consensus documents on CMPA. Only four CPGs (14.8%) achieved a high-quality AGREE II rating. The four high-quality CPGs consistently provided recommendations for CMPA. The highest scoring domains for AGREE II were \'scope and purpose\' (77 ± 12%) and \'clarity of presentation\' (75 ± 22%). The lowest scoring domains were \'stakeholder involvement\' (49 ± 21%), \'rigor of development\' (34 ± 20%) and \'applicability\' (12 ± 20%). Evaluation with AGREE-REX generally demonstrated low scores across its domains.   Conclusion: Recommendations within high-quality CPGs for the paediatric CMPA showed fundamental consistency. Nevertheless, the methodology and recommendation content of CPGs and the expert consensus exhibited low quality, thus indicating a substantial scope for enhancement. Guideline developers should rigorously follow the AGREE II and AGREE-REX standards in creating CPGs or expert consensuses to guarantee their clinical efficacy in managing paediatric CMPA. What is Known: • The quality of clinical practice guidelines and expert consensus on paediatric cow\'s milk protein allergy (CMPA) remains uncertain. • There is a lack of clarity regarding the consistency of crucial recommendations for CMPA management. What is New: • Improving the methodological quality of guidelines and consensus on CMPA requires greater emphasis on stakeholder engagement, rigorous development processes, and practical applicability. • The recommendations from four high-quality guidelines align. However, addressing clinical applicability, integrating values and preferences, and ensuring actionable implementation are critical to improving the quality of all guidelines.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:随机对照试验(RCT)通常是循证医学的基础,但RCT结果能否正确转化为临床实践取决于文献报道的质量.在这项研究中,我们评估了中国发表的儿科随机对照试验的一般特征和质量,为儿科随机对照试验的报告及其在临床实践中的应用提供证据.
    方法:我们对1999年1月1日至2022年12月30日在中国儿科期刊上发表的儿科随机对照研究进行了横断面观察研究。所有包括儿童(18岁以下)的RCT都被检索到,提取和分析RCT的一般特征。通过Cochrane质量评估方案评估随机对照试验的质量。
    结果:在筛选了20种可用的儿科期刊后,纳入3545个RCT用于分析。1999年至2022年发表的儿科随机对照试验数量的年均增长率为7.8%(P=0.005,R2=0.311)。大部分研究在华东地区进行[1148(32.4%];随机对照试验的中心主要是单中心[3453(97.4%],干预措施以药物为主[2442(68.9%)]。将2017-2022年发布的RCT与1999-2004年发布的RCT进行比较,RCT的质量在随机序列生成方面显着提高,分配隐藏,致盲参与者和人员,不完整的结果数据和选择性结果报告。确定了在中国科学引文数据库中多个中心发表的RCT,对于所有分析的偏倚风险项目,伦理委员会的批准质量更高.
    结论:近年来,中国报道的儿科随机对照试验的数量和质量有所提高,但总体质量相对较低。应特别注意隐藏分配和盲目性结果评估,和辍学,应报告不利影响和样本量计算。推动政府政策,加强期刊出版标准化和推进临床试验注册是可行的措施。
    BACKGROUND: Randomized controlled trials (RCTs) are usually the basis of evidence-based medicine, but whether the results of RCTs can be correctly translated into clinical practice depends on the quality of the literature reported. In this study, we evaluated the general characteristics and quality of paediatric RCTs published in China to provide evidence for the reporting of paediatric RCTs and their application in clinical practice.
    METHODS: We conducted a cross-sectional observational study of paediatric RCTs published in paediatric journals in China between January 1, 1999, and December 30, 2022. All RCTs that included children (younger than 18 years old) were retrieved, and the general characteristics of the RCTs were extracted and analysed. The quality of the RCTs was assessed by the Cochrane quality assessment protocol.
    RESULTS: After screening 20 available paediatric journals, 3545 RCTs were included for analysis. The average annual growth rate of the number of published paediatric RCTs from 1999 to 2022 was 7.8% (P = 0.005, R2 = 0.311). Most of the studies were carried out in East China [1148 (32.4%]; the centres of the RCTs were mainly single-centre [3453 (97.4%], and the interventions were mainly medication [2442 (68.9%)]. Comparing RCTs published in 2017-2022 with RCTs published in 1999-2004, the quality of RCTs significantly improved in terms of random sequence generation, allocation concealment, blinding participants and personnel, incomplete outcome data and selective outcome reporting. RCTs published in multiple centres from the Chinese Science Citation Database were identified, and the approval of the ethics committee was of better quality for all the analysed risk of bias items.
    CONCLUSIONS: The number and quality of paediatric RCTs reported in China have improved in recent years, but the overall quality was relatively low. Special attention should be given to allocation concealment and blinding outcome assessment, and dropouts, adverse effects and sample size calculations should be reported. Promoting government policies, strengthening the standardization of journal publishing and advancing the registration of clinical trials are feasible measures.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:评估糖尿病肾病(DKD)背景下临床实践指南(CPG)的质量,并确定是否有任何因素影响质量。
    方法:我们搜索了8个数据库以及5个国际和国家组织,以制定或存档从成立到2023年7月的指南,并额外搜索了medlive。cn.以及与肾脏病学相关的权威机构。使用DKD的直接鉴别诊断或治疗创建的CPG和共识声明不受语言限制。4名评审员使用《研究与评价指南Ⅱ》(AGREEⅡ)对其质量进行评价。随着项目和域得分,指南还被分配了一个整体质量分数,范围从1(最低质量)到7(最高质量)。此外,还分配了总体使用建议(“推荐”,\"建议修改\"或\"不建议\")。
    结果:共包括16个CPG,其中14个来自亚洲,其余两个来自欧洲。这两个CPG在第三个版本中进行了更新。建议使用六个CPG,因为它们的主要域得分在中等或高类别中。此外,作为利益相关者的参与,建议五个CPG进行修改,适用性,编辑独立性领域被评估为低类别。在所有域中,平均得分最低的是发展的严谨性(33%),其次是申请(36%),和利益相关者参与(51%)。平均得分最高的是范围和目的(79%),其次是表述的清晰度(75%)。没有一个CPG考虑了病人的观点,16个CPG中有6个没有使用任何分级系统将证据转化为建议.此外,16个CPG中只有三个共享搜索策略,16个CPG中有8个没有申报资金来源。
    结论:根据AGREEII评估,超过四分之一的DKDCPG的方法学质量差。需要加大力度推进发展的严峻性,应用程序,以及DKD指南小组对大多数指南的编辑独立性。利益相关者,CPG开发人员,CPG用户在选择CPG时应考虑方法学质量,并解释和执行他们提出的建议。
    OBJECTIVE: To assess the quality of Clinical practice guidelines (CPGs) in the context of diabetic kidney disease (DKD) and determine whether any factors affect the quality.
    METHODS: We searched eight databases along with five international and national organizations to develop or archive guidelines from their inception to July 2023, with an additional search of medlive.cn. And the authoritative organizations related to nephrology. CPGs and consensus statements created using direct differential diagnosis or therapy for DKD were included without language restrictions. Their quality was evaluated by four reviewers using the Appraisal of Guidelines for Research and Evaluation Ⅱ (AGREE Ⅱ) instrument. Along with the item and domain scores, the guideline was also allocated an overall quality score, which ranged from 1 (lowest possible quality) to 7 (highest possible quality). Moreover, an overall recommendation for use was also assigned (\"recommended\", \"recommended with modifications\" or \"not recommended\").
    RESULTS: A total of 16 CPGs were included, of which 14 were from Asia and the remaining two from Europe. These two CPGs were updated in the third version. Six CPGs were recommended for use because their primary domains scored in the medium or high category. Furthermore, five CPGs were recommended with modifications as the stakeholder involvement, applicability, and editorial independence domains were evaluated as low categories. In all domains, the lowest average score was for rigour of development (33%), followed by application (36%), and stakeholder involvement (51%). The highest average score was for scope and purpose (79%), followed by clarity of presentation (75%). None of the CPGs considered the patient\'s viewpoint, and six of 16 CPGs did not use any grading system to translate the evidence into recommendations. Additionally, only three of 16 CPGs shared search strategy, and eight of 16 CPGs did not declare a funding source.
    CONCLUSIONS: According to the AGREE II evaluation, more than one in four CPGs for DKD had poor methodological quality. Enhanced efforts are needed to advance the rigour of development, application, and editorial independence of DKD guideline panels for most guidelines. Stakeholders, CPG developers, and CPG users should consider methodological quality while choosing CPGs, and interpret and implement their issued suggestions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Systematic Review
    产后血钙(Ca)浓度与牛的繁殖和健康有关。在产牛后给予奶牛口服钙补充剂,以增加血液中的Ca浓度并降低低钙血症的风险。然而,研究表明,口服钙在预防疾病方面有不同的作用。这项研究的目的是(i)进行荟萃分析,以评估口服钙对产卵相关疾病发生率的预期影响,奶牛的怀孕风险和产奶量,(ii)对这些相关研究进行质量评估。总的来说,22项符合条件的研究纳入本综述。Meta分析显示口服钙可显著降低低钙血症的发生率(临床低钙血症:相对危险度(RR)=0.67,95%置信区间(CI)=[0.52,0.87];亚临床低钙血症:RR=0.81,CI=[0.72,0.91]),和胎盘滞留发生率(RR=0.77,CI=[0.62,0.95]),改善血液Ca浓度:平均差(MD)=0.08;95%CI=[0.04,0.11]。对于其他结果,荟萃分析显示,口服钙与血清镁(Mg)/磷(P)浓度之间缺乏相关性的证据(Mg:MD=-0.04;95%CI=[-0.10,0.02];P:MD=0.05;95%CI=[-0.10,0.21])或其他产牛相关疾病的发生率(meta:RR=1.06,RR=[0.94,1.19]1.19=1.18时的死亡率:[=1.91纳入研究形成的漏斗图的分布是对称的,Egger检验的p>0.05,表明没有明显的发表偏倚。敏感性分析结果表明,荟萃分析的结果是稳健的。对纳入研究的质量评估表明,偏倚的风险集中在选择偏倚上,性能偏差,检测偏差和其他偏差源,未来的研究应该集中在这些方面。
    Postpartum blood calcium (Ca) concentration is related to the reproduction and health of cattle. Oral calcium supplements were given to dairy cows after calving to increase blood Ca concentration and reduce the risk of hypocalcemia. However, studies have shown that oral Ca has different effects in preventing disease. The purposes of this study were (i) to conduct a meta-analysis to evaluate the expected effect of oral Ca on incidence of calving-related diseases, pregnancy risk and milk yield in dairy cows, and (ii) to make a quality assessment of these related studies. In total, 22 eligible studies were included in this review. Meta-analysis showed that oral Ca could significantly reduce the incidence of hypocalcemia (clinical hypocalcemia: relative risk (RR) = 0.67, 95% confidence interval (CI) = [0.52, 0.87]; subclinical hypocalcemia: RR = 0.81, CI = [0.72, 0.91]), and incidence of retained placenta (RR = 0.77, CI = [0.62, 0.95]), improved blood Ca concentrations: mean difference (MD) = 0.08; 95% CI = [0.04, 0.11]. For other results, the meta-analysis revealed a lack of evidence of the correlation between oral Ca and serum magnesium (Mg) / phosphorus (P) concentration (Mg: MD = -0.04; 95% CI = [-0.10, 0.02]; P: MD = 0.05; 95% CI = [-0.10, 0.21]) or incidence of other calving-related disorders (metritis: RR = 1.06, CI = [0.94, 1.19]; ketosis: RR = 1.04, CI = [0.91, 1.18]; mastitis: RR = 1.02, CI = [0.86, 1.21]; displacement of the abomasum: RR = 0.81, CI = [0.57, 1.16]) or pregnancy risk (pregnancy risk at first service: RR = 0.99, CI = [0.94, 1.05]; overall pregnancy rate: RR = 1.03, CI = [0.98, 1.08]) or milk yield (MD = 0.44; 95% CI = [-0.24, 1.13]). The distribution of the funnel plot formed by the included studies was symmetrical, and the Egger\'s test had a p > 0.05, indicating that there was no significant publication bias. Sensitivity analyses results suggested that the results of meta-analysis are robust. Quality assessment of the included studies revealed that the risk of bias was focused on selection bias, performance bias, detection bias and other sources of bias, and the future research should focus on these aspects.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在这项研究中,应用近红外(NIR)光谱和高效液相色谱(HPLC)结合化学计量学工具对不同品种和产地的苍术样品进行快速鉴别和定量分析。根据NIR数据,正交偏最小二乘判别分析(OPLS-DA)和K最近邻(KNN)模型对苍术的三个物种和两个起源的判别准确率均大于90%。此外,三种活性成分的含量(白术,atractylone,采用高效液相色谱法同时测定苍术中β-eudesmol)的含量。不同品种和产地的苍术样品中三种成分的含量存在显著差异。然后,偏最小二乘回归(PLSR)模型预测白术苷,atractylone,并成功建立了β-eudesmol含量。完整的苍术光谱产生了白术素的良好预测,atractylone,和β-eudesmol含量,R2值分别为0.9642、0.9588和0.9812。根据本研究的结果,可以得出结论,NIR是一种很好的非破坏性替代方法,可用作制药行业的快速分类系统。
    In this study, near-infrared (NIR) spectroscopy and high-performance liquid chromatography (HPLC) combined with chemometrics tools were applied for quick discrimination and quantitative analysis of different varieties and origins of Atractylodis rhizoma samples. Based on NIR data, orthogonal partial least squares discriminant analysis (OPLS-DA) and K-nearest neighbor (KNN) models achieved greater than 90% discriminant accuracy of the three species and two origins of Atractylodis rhizoma. Moreover, the contents of three active ingredients (atractyloxin, atractylone, and β-eudesmol) in Atractylodis rhizoma were simultaneously determined by HPLC. There are significant differences in the content of the three components in the samples of Atractylodis rhizoma from different varieties and origins. Then, partial least squares regression (PLSR) models for the prediction of atractyloxin, atractylone, and β-eudesmol content were successfully established. The complete Atractylodis rhizoma spectra gave rise to good predictions of atractyloxin, atractylone, and β-eudesmol content with R2 values of 0.9642, 0.9588, and 0.9812, respectively. Based on the results of this present research, it can be concluded that NIR is a great nondestructive alternative to be applied as a rapid classification system by the drug industry.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:本研究的目的是使用指南研究与评估(AGREEII)工具系统地评估与按摩相关的临床实践指南(CPGs)/共识的方法学质量,并总结CPGs中建议的现状。
    方法:中国国家知识基础设施(CNKI),万方数据,中国科技期刊数据库(VIP),中国生物医学光盘(CBM),PubMed,Embase,和指南网站(如中国医学王牌基地,中国中医药协会,世界卫生组织,国际网络准则,国家健康与护理卓越研究所,苏格兰校际指南网络)从开始到2022年10月31日进行了搜索。此外,回顾了相关研究的参考清单,以确定国内外按摩CPG/共识。搜索词采用了主题词和自由词的组合,主要包括中药,补充疗法,推拿,按摩,操纵,整脊/整骨疗法,脊柱,穴位按摩,指导方针,和共识。两名研究人员独立完成了符合条件的记录并提取了数据。在正式研究之前,在AGREEII上进行了两次校准,所有评审人员三次完成试点测试,直到他们理解并就评估项目达成一致。三名研究人员使用AGREEII仪器评估了纳入指南的方法学质量,并计算了协议的总体组内相关系数(ICC)。
    结果:评估结果显示,在49个合格的CPG/共识中,4个(8.2%)CPG/共识被认为是“推荐”,15(30.6%)CPG/共识被认为是“建议修改”,30个(61.2%)CPG/共识被认为“不推荐”,而共识被认为是“不建议”。一般来说,指南的六个领域的得分均高于共识。对36个CPGs的总体质量评估结果表明,有4个(11%)为“良好质量”,15人(42%)“质量足够”,17人(47%)“质量较低”。领域的AGREEII质量评分范围为0.30至0.75([ICC=0.993,95%CI(0.992,0.995)])。范围和目的域(域1),中位数为0.75(0.52~0.91),在AGREEII指南中表现最好,利益相关者参与(领域2)[中位数0.39(0.31〜0.56)]和应用(领域5)[中位数0.30(0.17〜0.47)获得了较低的分数。域1的一致得分为26.0(21.6~44.8),其次是严格的发展(领域3),得分18.0(10.0〜28.9)。从49条指引/共识中,共抽取119条按摩相关建议,包括“赞成”(102,85.7%),“反对”(9.7.6%),和“没有提出建议”(8,6.7%)。
    结论:纳入指南的总体质量较低,大多数指南都不是“推荐”。在未来的指南更新中,应该利用现有的证据,丰富专家组成员的专业组成,应充分考虑患者的价值观和偏好。有必要提出可识别的建议,并加强指南制定的严谨性和标准化。因此,可制定明确的标准指南,更好地指导临床实践。
    OBJECTIVE: The purpose of this study was to systematically evaluate the methodological quality of massage-related clinical practice guidelines (CPGs)/consensus on massage using the Appraisal of Guidelines Research and Evaluation (AGREE II) instrument and to summarize the current status of recommendations in the CPGs.
    METHODS: The Chinese National Knowledge Infrastructure (CNKI), WanFang Data, China Science and Technology Journal Database (VIP), China Biology Medicine disc (CBM), PubMed, Embase, and guideline websites (such as the Chinese Medical Ace Base, the China Association of Chinese Medicine, the World Health Organization, Guideline International Network, National Institute for Health and Care Excellence, Scottish Intercollegiate Guidelines Network) were searched from inception to October 31, 2022. In addition, the reference lists of relevant studies were reviewed to identify domestic and overseas massage CPGs/consensus. The search terms adopted a combination of subject words and free words, mainly including traditional Chinese medicine, complementary therapies, Tuina, massage, manipulation, chiropractic/osteopathic, spinal, acupressure, guideline, and consensus. Two researchers independently completed the eligible records and extracted the data. Before the formal research, calibrations were performed twice on AGREE II, and all reviewers completed the pilot test three times until they understood and reached an agreement on the assessment items. Three researchers appraised the methodological quality of the included guidelines using the AGREE II instrument and calculated the overall intraclass correlation coefficient (ICC) of agreement.
    RESULTS: The evaluation results showed that among the 49 eligible CPGs/consensus, 4 (8.2%) CPGs/consensus were considered \"recommended\", 15 (30.6%) CPGs/consensus were considered \"recommended with modifications\", and 30 (61.2%) CPGs/consensus were considered \"not recommended\", while the consensus was considered \"not recommended\". Generally, the scores in the six domains of the guidelines were all higher than the consensus. Evaluation results for the overall quality of 36 CPGs showed that 4 (11%) were \"good quality\", 15 (42%) were \"sufficient quality\" and 17 (47%) were \"lower quality\". The AGREE II quality scores of domains ranged from 0.30 to 0.75 ([ICC = 0.993, 95% CI (0.992, 0.995)]). The domain of scope and purpose (domain 1), with a median score of 0.75 (0.52~0.91), performed best in the guidelines with AGREE II, and stakeholder involvement (domain 2) [median 0.39 (0.31~0.56)] and application (domain 5) [median 0.30 (0.17~0.47] obtained lower scores. The consensus score of domain 1 was better at 26.0 (21.6~44.8), followed by rigor of development (domain 3) with a score of 18.0 (10.0~28.9). A total of 119 massage-related recommendations were extracted from 49 guidelines/consensuses, including \"in favor\" (102, 85.7%), \"against\" (9, 7.6%), and \"did not make recommendations\" (8, 6.7%).
    CONCLUSIONS: The overall quality of the included guidelines was low, and most of the guidelines were not \"recommended\". In future guideline updates, the existing evidence should be used, the professional composition of members of the expert group should be enriched, and patients\' values and preferences should be fully considered. It is necessary to clearly propose recognizable recommendations and strengthen the rigor and standardization of guideline formulation. Thus, clear standard guidelines can be formulated to better guide clinical practice.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Editorial
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    水分含量(MC)的控制在虾的干燥中至关重要,直接影响其质量和保质期。本研究旨在通过将高光谱成像(HSI)与电子鼻(E-nose)技术相结合,开发一种准确的测定虾MC的方法。我们采用了三种不同的数据融合方法:像素-,feature-,和决策融合,结合HSI和E鼻数据进行对虾MC的预测。我们为每种方法开发了偏最小二乘回归(PLSR)模型,并在预测精度方面比较了它们的性能。决策融合方法优于其他方法,为校准集(0.9595)和验证集(0.9448)产生最高的测定系数。校准集(0.0370)和验证集(0.0443)的相应均方根误差最低,表明预测精度高。此外,这种方法实现了3.94的相对百分比偏差,在所测试的方法中最高。研究结果表明,通过PLSR模型对HSI和E鼻数据进行决策融合是一种有效的,准确,评价虾MC的有效方法。这种方法的证明能力使其成为干虾产品质量控制和市场监测的宝贵工具。
    The control of moisture content (MC) is essential in the drying of shrimp, directly impacting its quality and shelf life. This study aimed to develop an accurate method for determining shrimp MC by integrating hyperspectral imaging (HSI) with electronic nose (E-nose) technology. We employed three different data fusion approaches: pixel-, feature-, and decision-fusion, to combine HSI and E nose data for the prediction of shrimp MC. We developed partial least squares regression (PLSR) models for each method and compared their performance in terms of prediction accuracy. The decision fusion approach outperformed the other methods, producing the highest determination coefficients for both calibration (0.9595) and validation sets (0.9448). Corresponding root-mean square errors were the lowest for the calibration set (0.0370) and validation set (0.0443), indicating high prediction precision. Additionally, this approach achieved a relative percent deviation of 3.94, the highest among the methods tested. The findings suggest that the decision fusion of HSI and E nose data through a PLSR model is an effective, accurate, and efficient method for evaluating shrimp MC. The demonstrated capability of this approach makes it a valuable tool for quality control and market monitoring of dried shrimp products.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号